Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins - PubMed (original) (raw)

Review

Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins

I Mocchetti. Cell Mol Life Sci. 2005 Oct.

Abstract

Gangliosides, a heterogeneous family of glycosphingolipids abundant in the brain, have been shown to affect neuronal plasticity during development, adulthood and aging. This review will examine old and recent evidence that exogenous gangliosides and in particular GM1, the prototype member of this family, exhibit multimodal neurotrophic effects. Since these compounds are a potential therapeutic tool for the treatment of various forms of acute or chronic neurodegenerative diseases, understanding the dynamic interplay of gangliosides and neuronal cells is essential in the effort to cure neurological disorders. Focus will be given to the novel and provocative hypothesis that gangliosides' neuroprotective properties may derive from their ability to mimic endogenous neurotrophic factors.

PubMed Disclaimer

Similar articles

• Exogenous gangliosides increase the release of brain-derived neurotrophic factor.
  Lim ST, Esfahani K, Avdoshina V, Mocchetti I. Lim ST, et al. Neuropharmacology. 2011 Jun;60(7-8):1160-7. doi: 10.1016/j.neuropharm.2010.10.012. Epub 2010 Oct 28. Neuropharmacology. 2011. PMID: 20971126 Free PMC article.
• [Gangliosides in neurological pharmacotherapy].
  Małecki A, Małecka E, Trzeciak HI. Małecki A, et al. Neurol Neurochir Pol. 1992 Sep-Oct;26(5):695-701. Neurol Neurochir Pol. 1992. PMID: 1291908 Review. Polish.
• Targeting neurotrophin receptors in the central nervous system.
  Mocchetti I, Brown M. Mocchetti I, et al. CNS Neurol Disord Drug Targets. 2008 Feb;7(1):71-82. doi: 10.2174/187152708783885138. CNS Neurol Disord Drug Targets. 2008. PMID: 18289034 Review.
• [Recent progress in the study of gangliosides].
  Abe T, Ogawa K. Abe T, et al. No To Hattatsu. 1986 May;18(3):169-73. No To Hattatsu. 1986. PMID: 3518757 Review. Japanese. No abstract available.
• Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells.
  Dunbar GL, Sandstrom MI, Rossignol J, Lescaudron L. Dunbar GL, et al. Behav Cogn Neurosci Rev. 2006 Jun;5(2):63-79. doi: 10.1177/1534582306289367. Behav Cogn Neurosci Rev. 2006. PMID: 16801683 Review.

Cited by

• Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson's disease: potential therapeutic targets?
  Jiang TF, Chen SD. Jiang TF, et al. Neurosci Bull. 2012 Oct;28(5):649-57. doi: 10.1007/s12264-012-1263-1. Epub 2012 Sep 8. Neurosci Bull. 2012. PMID: 22961477 Free PMC article. Review.
• Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.
  Arbor SC, LaFontaine M, Cumbay M. Arbor SC, et al. Yale J Biol Med. 2016 Mar 24;89(1):5-21. eCollection 2016 Mar. Yale J Biol Med. 2016. PMID: 27505013 Free PMC article. Review.
• Co-segregation of AMPA receptors with G(M1) ganglioside in synaptosomal membrane subfractions.
  Cole AA, Dosemeci A, Reese TS. Cole AA, et al. Biochem J. 2010 Apr 14;427(3):535-40. doi: 10.1042/BJ20091344. Biochem J. 2010. PMID: 20148761 Free PMC article.
• Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.
  Gil-Tommee C, Vidal-Martinez G, Annette Reyes C, Vargas-Medrano J, Herrera GV, Martin SM, Chaparro SA, Perez RG. Gil-Tommee C, et al. Exp Neurol. 2019 Jan;311:265-273. doi: 10.1016/j.expneurol.2018.10.014. Epub 2018 Oct 25. Exp Neurol. 2019. PMID: 30393144 Free PMC article.
• FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice.
  Vidal-Martinez G, Najera K, Miranda JD, Gil-Tommee C, Yang B, Vargas-Medrano J, Diaz-Pacheco V, Perez RG. Vidal-Martinez G, et al. Neuroscience. 2019 Jul 15;411:1-10. doi: 10.1016/j.neuroscience.2019.05.029. Epub 2019 May 23. Neuroscience. 2019. PMID: 31129200 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information